Delivery Order SPE2DB22D2007-SPE2DB25FJ0FW

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,360.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Telmisartan-Amlodipine 40-5 mg tablets, a cardiovascular medication, with a period of performance through January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,373.92, is for the delivery of telmisartan-amlodipine 80-10 30S, a medication used to treat high blood pressure and heart disease. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,367.90, is for the delivery of 4567677114 - Telmisartan-HCTZ 80-12.5 mg tablets in units of 30. The contract is a firm fixed-price agreement with a performance period ending on March 25, 2025. This delivery order contract is awarded under a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,384.80 firm fixed-price contract is for the delivery of 80 mg Telmisartan tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of September 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This $1,584.47 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4567301009 - Telmisartan-HCTZ 80-25 mg Tablet Unit Dose 30s, with a completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, a cardiovascular medication, with a ceiling value of $4,917.96 and a performance period through March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563118190 - Telmisartan-Amlodipine 40-10 30 tablets, with a firm fixed price ceiling value of $1,644.20 and a completion date of December 18, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $17,101.19 firm fixed-price contract is for the supply of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has a performance period through January 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-Amlodipine 40-10 mg tablets. The contract has a ceiling value of $3,246.15 and a period of performance through May 14, 2024. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,401.79, is for the delivery of TELMISARTAN-AMLODIPINE 40-5 MG 30S, a cardiovascular medication, with a period of performance through December 18, 2024. The contract is a firm-fixed-price delivery order contract, and there is no set-aside designation indicated. AmerisourceBergen...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0FW
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,076.23, is for the delivery of telmisartan-amlodipine 40-5 mg tablets. This order is placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order has a firm fixed price and no set-aside designation, indicating open competition.

Generated 6/26/25, 10:21 AM